Primary Care Clinics in Lauderdale By The Sea, FL Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Oband Medical Group Internal Medicine - Obesity Medicine Medicare: Not Enrolled in Medicare Practice Location: 4401 West Tradewinds Ave, 205, Lauderdale By The Sea, FL 33308 Phone: 954-900-3635 |
Craig Depodesta, Do, Pa General Practice Medicare: Not Enrolled in Medicare Practice Location: 231b Commercial Blvd, Lauderdale By The Sea, FL 33308 Phone: 954-530-1600 Fax: 954-306-8234 |
Andrew Greenberg Md Pa Internal Medicine Medicare: Medicare Enrolled Practice Location: 4617 El Mar Dr, Lauderdale By The Sea, FL 33308 Phone: 631-827-7415 Fax: 954-771-2955 |
Bayview General Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4401 W Tradewinds Ave, 3rd Floor, Lauderdale By The Sea, FL 33308 Phone: 954-776-6992 Fax: 954-776-6969 |
News Archive
Study shows spillover effect of evidence-based opioid prescribing for major procedures
To curb the use of opioids after major elective operations and prevent these pain relievers from falling into the wrong hands, surgeons at the University of Michigan developed prescribing recommendations based on published medical evidence for one operation, gall bladder removal, and then discovered a spillover effect that led them to prescribe roughly 10,000 fewer pills for other major operations, according to study results appearing as an "article in press" on the website of the Journal of the American College of Surgeons ahead of print.
New Nationwide Children's app aims to help make homes safer for children
Nationwide Children's Hospital is joining Nationwide - one of the largest and strongest diversified insurance and financial services organizations in the U.S. - in their effort to prevent childhood injury. According to the Centers for Disease Control and Prevention, and many injuries occur in and around the home. Through this new Make Safe Happen initiative, Nationwide Children's researchers developed a new Make Safe Happen app to help prevent childhood injury.
New MyoVista hsECG device launched in the European Union for early detection of heart disease
HeartSciences today announced the European launch of MyoVista high sensitivity electrocardiograph (hsECG) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients.
Multi-institutional clinical trial sheds new light on non-responsive tumors
Over the last decade, enzalutamide and similar drugs have led to significant tumor control and increased survival time for men who have metastatic prostate cancer that continues to grow despite treatments to reduce male hormone levels.
› Verified 4 days ago